Repositioning For Allosteric Modulation of VIP and PACAP Receptors VIPPACAP 5 Mar Written by Aleks Langer I, Latek D. Drug . Front Endocrinol (Lausanne). 2021 Nov 18;12:711906. doi: 10.3389/fendo.2021.711906. eCollection 2021. Aleks Previous Previous Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches Next Next Involvement of chemerin and CMKLR1 in the progesterone decrease by PCOS granulosa cells
Repositioning For Allosteric Modulation of VIP and PACAP Receptors VIPPACAP 5 Mar Written by Aleks Langer I, Latek D. Drug . Front Endocrinol (Lausanne). 2021 Nov 18;12:711906. doi: 10.3389/fendo.2021.711906. eCollection 2021. Aleks
